## Abstract ## BACKGROUND. Obesity is considered a risk factor for the development of breast cancer‐related lymphedema of the arm and as a poor prognostic factor in response to lymphedema treatment. The objective of this study was to examine weight reduction as a treatment for breast cancer‐relate
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial
✍ Scribed by Ian S. Dayes; Mark N. Levine; J. A. Julian; Kathleen I. Pritchard; David P. D’Souza; Lyn Kligman; Donnalue Reise; Jennifer A. Wiernikowski; L. Bonilla; T. J. Whelan
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 238 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recent case-referent studies in the Nijmegen breast-screening programme have shown a reduction in breast-cancer mortality of approximately 50% due to screening of women aged 65 years and older. In this type of study, however, the results may be biased because of self-selection. The purpose of our pr
A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and C M F P (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone). Both r
## Abstract ## BACKGROUND. Obesity is considered a risk factor for lymphedema of the arm resulting from breast cancer treatment (BCRL) as well as a poor prognostic factor in response to lymphedema treatment. The aim of the study was to compare the effect of 2 dietary interventions on excess arm vo